Related Experiment Video
Updated: Sep 6, 2025

08:51
Human Egg Maturity Assessment and Its Clinical Application
Published on: August 19, 2019
19.5K
Metaphase II (MII) human oocytes with smooth endoplasmic reticulum clusters do not affect blastocyst euploid rate
Christine Shan-Chi Chiu1, Tzu-Yu Hung2, Ming-Huei Lin3
1Department of Obstetrics and Gynecology, MacKay Memorial Hospital, Taipei, Taiwan.
Taiwanese Journal of Obstetrics & Gynecology
|July 2, 2022
Summary
Oocyte dysmorphisms, including smooth endoplasmic reticulum clusters (SERc), do not significantly impact euploidy rates or blastocyst development. Embryos from oocytes with SERc can still be viable options for transfer, offering potential for healthy pregnancies.
Area of Science:
- Reproductive biology
- Human embryology
- In vitro fertilization
Background:
- Oocyte morphology is a key factor in assessing reproductive potential.
- Dysmorphisms in mature human oocytes, such as smooth endoplasmic reticulum clusters (SERc), are observed but their impact on euploidy and pregnancy outcomes is not fully understood.
Purpose of the Study:
- To determine if specific oocyte dysmorphisms, particularly SERc, affect the euploidy rate of resulting blastocysts.
- To evaluate the relationship between oocyte morphology and pregnancy outcomes following preimplantation genetic testing for aneuploidies (PGT-A).
Main Methods:
- Retrospective analysis of 590 biopsied blastocysts from 109 patients undergoing PGT-A cycles.
- Morphological assessment of metaphase II (MII) oocytes.
- Chromosome status determined by array comparative genomic hybridization (aCGH) or next-generation sequencing (NGS).
Main Results:
- No statistically significant relationship was found between oocyte dysmorphisms and the euploid rate of blastocysts.
- Oocytes with SERc showed a trend towards higher 2-pronuclei arrest but did not affect blastocyst formation rates.
- Two healthy singleton births resulted from embryo transfers derived from oocytes with SERc.
Conclusions:
- Oocyte dysmorphisms, including SERc, do not appear to compromise blastocyst euploidy rates or embryo formation.
- Embryos originating from oocytes with SERc are potentially viable and can be considered for transfer, especially when alternative options are limited.
Related Concept Videos
Meiosis II
184.2K
Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each...
184.2K
Cleavage and Blastulation
45.6K
After a large-single-celled zygote is produced via fertilization, the process of cleavage occurs while zygotes travel through the uterine tube. Cleavage is a mitotic cell division that does not result in growth. With each round of successive cell division, daughter cells get increasingly smaller.
45.6K
Oogenesis
64.2K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
64.2K
Nondisjunction
4.0K
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers. Nondisjunction is common during anaphase I or anaphase II of meiosis. Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...
4.0K

